EW insider buying and SEC filings, explained
Edwards Lifesciences Corp · CIK 1099800
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$7.8M
Planned sales (10b5-1)
$14.5M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 8, 2026 | Planned (10b5-1) | Daniel J. Lippis (Cvp, Tavr) sold 619 shares at $85.65 ($53K), marked as a 10b5-1 plan trade. Holdings down 2% to 40,034 shares. | SEC filing Filed Oct 8, 2026, 5:24 PM ET |
| Sep 11, 2026 | Planned (10b5-1) | Daniel J. Lippis (Cvp, Tavr) sold 619 shares at $87.51 ($54K), marked as a 10b5-1 plan trade. Holdings down 2% to 40,034 shares. | SEC filing Filed Sep 11, 2026 |
| Aug 31, 2026 | Sale | Andrew M. Dahl (SVP, Corporate Controller) sold 544 shares at $91.06 ($50K). Holdings down 4% to 14,868 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 31, 2026 |
| Aug 28, 2026 | Sale | Annette Bruls (Cvp, Emeacla) sold 2,644 shares at $89.98 ($238K). Holdings down 13% to 17,984 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 28, 2026 |
| Aug 26, 2026 | Sale | Wayne Markowitz (Cvp, Japac) sold 1,240 shares at $91.47 ($113K). Holdings down 6% to 20,294 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 26, 2026 |
| Aug 11, 2026 | Planned (10b5-1) | Daniel J. Lippis (Cvp, Tavr) sold 619 shares at $92.03 ($57K), marked as a 10b5-1 plan trade. Holdings down 2% to 40,034 shares. | SEC filing Filed Aug 11, 2026 |
| Jul 30, 2026 | Sale | Wayne Markowitz (Cvp, Japac) sold 146 shares at $86.03 ($13K). Holdings down 1% to 21,534 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 30, 2026 |
| Jul 27, 2026 | Sale | Bernard J Zovighian (CEO and Director) sold 2,921 shares indirectly (by trust) at $83.93 ($245K). Holdings by trust down 25% to 8,916 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 27, 2026 |
| Jul 10, 2026 | Planned (10b5-1) | Daniel J. Lippis (Cvp, Tavr) sold 619 shares at $91.70 ($57K), marked as a 10b5-1 plan trade. Holdings down 2% to 40,034 shares. | SEC filing Filed Jul 10, 2026 |
| Jun 30, 2026 | Planned (10b5-1) | Daniel J. Lippis (Cvp, Tavr) sold 619 shares at about $91.40 ($57K), marked as a 10b5-1 plan trade. Holdings down 2% to 40,411 shares. | SEC filing Filed Jun 30, 2026 |
| Jun 17, 2026 | Planned (10b5-1) | Bernard J Zovighian (CEO and Director) sold 523 shares indirectly (by trust) at $87.92 ($46K), marked as a 10b5-1 plan trade. Holdings by trust down 4% to 11,517 shares. | SEC filing Filed Jun 17, 2026 |
| May 29, 2026 | Sale | Andrew M. Dahl (SVP, Corporate Controller) sold 568 shares at $86.08 ($49K). Holdings down 4% to 15,334 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 29, 2026 |
| May 27, 2026 | Sale | Donald E. Bobo Jr. (CVP,Strategy/Corp Development) sold 23,145 shares indirectly (by trust) at about $86.42 ($2.0M). Holdings by trust down 19% to 98,611 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 27, 2026 |
| May 22, 2026 | Sale | Daveen Chopra (CVP, TMTT & Surgical) sold 1,500 shares at about $84.60 ($127K). Holdings down 3% to 44,324 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 22, 2026 |
| May 18, 2026 | Planned (10b5-1) | Daniel J. Lippis (Cvp, Tavr) sold 620 shares at $81.14 ($50K), marked as a 10b5-1 plan trade. Holdings down 2% to 40,411 shares. | SEC filing Filed May 18, 2026 |
| May 15, 2026 | Sale | Donald E. Bobo Jr. (CVP,Strategy/Corp Development) sold 17,968 shares directly and indirectly (by retirement or benefit plan) at about $81.96 ($1.5M). Direct holdings down 30% to 22,798 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 18, 2026 |
| May 12, 2026 | Planned (10b5-1) | Bernard J Zovighian (CEO and Director) sold 36,351 shares indirectly (by trust) at about $77.93 ($2.8M), marked as a 10b5-1 plan trade. Holdings by trust down 75% to 12,040 shares. | SEC filing Filed May 12, 2026 |
| May 11, 2026 | Sale | Wayne Markowitz (Cvp, Japac) sold 593 shares at $79.73 ($47K). Holdings down 3% to 21,680 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 11, 2026 |
| May 1–4, 2026 | Planned (10b5-1) | Daniel J. Lippis (Cvp, Tavr) sold 2,038 shares between May 1 and May 4 at about $83.49 ($170K), marked as a 10b5-1 plan trade. Holdings down 6% to 33,682 shares. | SEC filing Filed May 4, 2026 |
| Apr 9, 2026 | Planned (10b5-1) | Scott B. Ullem (CFO) sold 13,000 shares at about $80.05 ($1.0M), marked as a 10b5-1 plan trade. Holdings down 25% to 39,699 shares. | SEC filing Filed Apr 9, 2026 |
| Apr 6, 2026 | Planned (10b5-1) | Daniel J. Lippis (Cvp, Tavr) sold 1,019 shares at about $80.98 ($83K), marked as a 10b5-1 plan trade. Holdings down 3% to 33,934 shares. | SEC filing Filed Apr 6, 2026 |
| Apr 2, 2026 | Planned (10b5-1) | Donald E. Bobo Jr. (CVP,Strategy/Corp Development) sold 22,680 shares at about $80.16 ($1.8M), marked as a 10b5-1 plan trade. Holdings down 52% to 21,266 shares. | SEC filing Filed Apr 2, 2026 |
| Mar 11, 2026 | Planned (10b5-1) | Scott B. Ullem (CFO) sold 13,000 shares at about $84.92 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 25% to 39,699 shares. | SEC filing Filed Mar 11, 2026 |
| Mar 11, 2026 | Planned (10b5-1) | Daniel J. Lippis (Cvp, Tavr) sold 1,019 shares at about $85.38 ($87K), marked as a 10b5-1 plan trade. Holdings down 3% to 33,934 shares. | SEC filing Filed Mar 11, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Donald E. Bobo Jr. (CVP,Strategy/Corp Development) sold 11,340 shares at about $85.93 ($974K), marked as a 10b5-1 plan trade. Holdings down 35% to 21,266 shares. | SEC filing Filed Mar 2, 2026 |
| Feb 25, 2026 | Sale | Donald E. Bobo Jr. (CVP,Strategy/Corp Development) sold 24,000 shares at about $83.84 ($2.0M). Holdings down 53% to 21,266 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 26, 2026 |
| Jan 9, 2026 | Planned (10b5-1) | Daniel J. Lippis (Cvp, Tavr) sold 1,019 shares at about $85.70 ($87K), marked as a 10b5-1 plan trade. Holdings down 4% to 22,002 shares. | SEC filing Filed Jan 9, 2026 |
| Jan 6, 2026 | Planned (10b5-1) | Donald E. Bobo Jr. (CVP,Strategy/Corp Development) sold 11,340 shares at about $85.66 ($971K), marked as a 10b5-1 plan trade. Holdings down 26% to 31,870 shares. | SEC filing Filed Jan 6, 2026 |
| Dec 12, 2025 | Sale | Donald E. Bobo Jr. (CVP,Strategy/Corp Development) sold 11,386 shares at about $83.76 ($954K). Holdings down 23% to 38,970 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 12, 2025 |
| Dec 12, 2025 | Planned (10b5-1) | Daniel J. Lippis (Cvp, Japac) sold 1,019 shares at about $84.03 ($86K), marked as a 10b5-1 plan trade. Holdings down 4% to 22,002 shares. | SEC filing Filed Dec 12, 2025 |
| Dec 12, 2025 | Sale | Heisz Leslie Stone (Director) sold 2,615 shares at $83.41 ($218K). Holdings down 8% to 30,948 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 12, 2025 |
| Dec 11, 2025 | Sale | Daveen Chopra (CVP, TMTT & Surgical) sold 2,000 shares at $84.38 ($169K). Holdings down 6% to 32,201 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 11, 2025 |
| Dec 10, 2025 | Planned (10b5-1) | Donald E. Bobo Jr. (CVP,Strategy/Corp Development) sold 11,340 shares at about $83.83 ($951K), marked as a 10b5-1 plan trade. Holdings down 18% to 50,356 shares. | SEC filing Filed Dec 10, 2025 |
| Dec 8–10, 2025 | Planned (10b5-1) | Bernard J Zovighian (CEO and Director) sold 25,350 shares directly and indirectly (by trust) between Dec 8, 2025 and Dec 10, 2025 at about $84.94 ($2.2M), marked as a 10b5-1 plan trade. Direct holdings down 20% to 84,839 shares. | SEC filing Filed Dec 10, 2025 |
| Dec 9, 2025 | Planned (10b5-1) | Scott B. Ullem (CFO) sold 7,700 shares at about $84.47 ($650K), marked as a 10b5-1 plan trade. Holdings down 16% to 39,898 shares. | SEC filing Filed Dec 9, 2025 |
| Dec 8, 2025 | Sale | Wayne Markowitz (Cvp, Japac) sold 583 shares at $86.01 ($50K). Holdings down 3% to 17,563 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 8, 2025 |
| Nov 10, 2025 | Planned (10b5-1) | Scott B. Ullem (CFO) sold 13,000 shares at about $83.08 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 25% to 39,898 shares. | SEC filing Filed Nov 10, 2025 |
| Nov 10, 2025 | Planned (10b5-1) | Daniel J. Lippis (Cvp, Japac) sold 1,020 shares at about $82.55 ($84K), marked as a 10b5-1 plan trade. Holdings down 4% to 22,002 shares. | SEC filing Filed Nov 10, 2025 |
65 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow EW in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.